Characteristics of a new antithrombin DNA-aptamer RE31 were studied. This aptamer inhibited thrombin formation in human plasma catalyzed by exogenous (lengthening of thrombin time) and endogenous thrombin (lengthening of partial prothrombin time and activated partial thromboplastin time). In addition, the aptamer completely suppressed thrombin-induced aggregation of human platelets. On the other hand, RE31 did not reduce amidolytic activity of thrombin towards the short peptide substrate, in other words, did not modify the state of enzyme active center. By the capacity to inhibit clotting reactions, RE31 was superior to the previously described highly effective 31-component antithrombin aptamer 31TBA (thrombin binding aptamer, TBA). The effect of RE31 was species-specifi c: it inhibited human thrombin activity more effectively than activities of rat and rabbit thrombins.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. B. Dobrovolsky, E. V. Titaeva, S. G. Khaspekova, et al., Byull. Eksp. Biol. Med., 147, No. 7, 41–45 (2009).
A. V. Kul’bachinskii, Uspekhi Biol. Khim., 246, 193–224 (2009).
V. A. Spiridonova, E. V. Rog, T. N. Dugina, et al., Bioorgan. Khim., 29, No. 5, 495–498 (2003).
L. C. Bock, L. C. Griffin, J. A. Latham, et al., Nature, 355, 564–566 (1992).
M. Di Nisio, S. Middeldorp, and H. R. Buller, N. Engl. J. Med., 353, No. 10, 1028–1040 (2005).
A. D. Ellington and J. W. Szostak, Nature, 346, 818–822 (1990).
L. C. Griffi n, G. F. Tidmarsh, L. C. Bock, et al., Blood, 81, No. 12, 3271–3276 (1993).
K. Ikebukuro, Y. Okumura, K. Sumikara, and I. Karube, Nucleic Acid Res., 33, No. 12, e108 (2005).
S. M. Nimjee, C. P. Rusconi, R. A. Harrington, and B. A. Sullenger, Trends Cardiovasc. Med., 15, No. 1, 41–45 (2005).
K. Padmanabhan, K. P. Padmanabhan, J. D. Ferrara, et al., J. Biol. Chem., 268, No. 24, 17,651-17,654 (1993).
C. Tuerk and L. Gold, Science, 249, 505–510 (1990).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 150, No. 10, pp. 394–397, October, 2010
Rights and permissions
About this article
Cite this article
Mazurov, A.V., Titaeva, E.V., Khaspekova, S.G. et al. Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin. Bull Exp Biol Med 150, 422–425 (2011). https://doi.org/10.1007/s10517-011-1158-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-011-1158-6